Ask Finn← Discover
TOP STORIES

CVS Health Is Breaking Up Its Healthcare Empire Into Two Separate Companies

By Riley Carter · Thursday, November 5, 2026
Finn's Take· TL;DR
  • CVS Health will split into two companies: CVS Pharmacy (retail stores, clinics) and CVS Health (insurance, PBM, care services), completing in mid-2028.
  • Stock plunged 13% as investors worry the breakup dismantles the vertical integration strategy CVS built over decades through major acquisitions.
  • Regulatory pressure and state laws restricting drug pricing and pharmacy ownership prompted the split, raising questions about healthcare consolidation's future.
See this from any side — with sources:
Left takeNeutralRight take

A Healthcare Giant Splits in Two

CVS Health announced on Wednesday it will split into two companies, separating retail pharmacy from its insurance and pharmacy-benefit operations — a major unwinding of the healthcare conglomerate it spent years building through acquisitions. The announcement, made on November 4, sent shockwaves through Wall Street and the broader healthcare industry, raising questions about the future of vertically integrated healthcare in America.

CVS shares were down 13% in afternoon trade, putting the company on track to lose nearly $15 billion in market value. The steep drop reflects investor uncertainty about a breakup that, while potentially unlocking long-term value, dismantles a business model CVS spent decades constructing.

What the Two New Companies Will Look Like

The company retaining the CVS Health name will be a healthcare services company that includes insurance giant Aetna, value-based care group Oak Street Health, pharmacy benefit manager CVS Caremark, and at-home care group Signify Health. CVS Pharmacy will consist of the physical retail pharmacies, mail pharmacy, MinuteClinic urgent care, and health navigation and engagement platform Health100.

CVS Health CEO David Joyner will lead the healthcare solutions company, while Group President Prem Shah will become CEO of CVS Pharmacy. Upon completion of the separation, CVS Health shareholders will own shares in both companies. CVS Health said it expects both companies to hold solid investment-grade ratings and to pay a dividend. The split is expected to be completed in the first half of 2028.

The Road That Led Here

This breakup is a striking reversal of fortune for a company that once bet its entire future on consolidation. The split brings CVS back to being a standalone pharmacy chain for the first time since 2006, when it purchased the Caremark PBM. That strategy accelerated dramatically when CVS completed its roughly $78 billion acquisition of health insurer Aetna in 2018, placing the company at the center of an increasingly contentious national debate over healthcare costs and conflicts of interest.

The split "unwinds a central piece of the premise" behind CVS' acquisitions: "that a pharmacy, PBM, insurer, and care-delivery organization could coordinate more of the healthcare journey and create economies of scale," according to Forrester principal analyst Arielle Trzcinski. Meanwhile, the split comes amid growing scrutiny from lawmakers and regulators of vertically integrated healthcare companies such as CVS. Tennessee and Arkansas recently passed laws barring companies from both negotiating drug prices and owning pharmacies in the same state, and CVS has sued to block those laws. At least 10 other states and federal lawmakers are considering similar legislation.

What This Means for Patients and the Industry

The planned breakup is the latest in a series of major corporate splits this decade as companies look to simplify operations and boost shareholder returns. But for everyday Americans, the implications run deeper than stock prices. CVS's integrated model was originally sold to the public as a way to make healthcare cheaper and more seamless — one company handling your insurance, your prescriptions, and your clinic visit. The split signals that model may have created more problems than it solved.

Analysts viewed the potential split positively, saying the timing was favorable as CVS's Pharmacy and Consumer Wellness business had returned to growth after years of underperformance. CVS Pharmacy plans to expand services from its nearly 30,000 pharmacists and to pursue partnerships with payers, pharmacy benefit managers and manufacturers. Whether two leaner, more focused companies can deliver on the promise of affordable, accessible care — the very promise that justified the original mega-mergers — will be the defining question of CVS's next chapter, and perhaps a bellwether for how Washington regulates healthcare consolidation for years to come.

Have a question about this story?
Ask Finn — answers grounded in this article, from any viewpoint.